Copyright Reports & Markets. All rights reserved.

Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Over-the-counter (OTC) Testing Kits
      • 1.4.3 Prescription-based Testing Kits
    • 1.5 Market by Application
      • 1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2025)
      • 1.5.2 Bacterial Infections
      • 1.5.3 Fungal Infection
      • 1.5.4 Virus Infection
      • 1.5.5 Cardiovascular Infection
      • 1.5.6 Gastrointestinal Infection
      • 1.5.7 Sexually Transmitted Disease (STD) Infection
      • 1.5.8 Central Nervous System Infection
      • 1.5.9 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Infectious Disease Point of Care Diagnostics Market Size
    • 2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
      • 2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions (2019-2025)
      • 2.2.2 Infectious Disease Point of Care Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Infectious Disease Point of Care Diagnostics Market Size by by Players
      • 3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by by Players (2014-2019)
      • 3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Infectious Disease Point of Care Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Infectious Disease Point of Care Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Infectious Disease Point of Care Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 5.2 Infectious Disease Point of Care Diagnostics Key Players in North America
    • 5.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type
    • 5.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 6.2 Infectious Disease Point of Care Diagnostics Key Players in Europe
    • 6.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
    • 6.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application

    7 China

    • 7.1 China Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 7.2 Infectious Disease Point of Care Diagnostics Key Players in China
    • 7.3 China Infectious Disease Point of Care Diagnostics Market Size by Type
    • 7.4 China Infectious Disease Point of Care Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 8.2 Infectious Disease Point of Care Diagnostics Key Players in Japan
    • 8.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type
    • 8.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 9.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type
    • 9.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application

    10 India

    • 10.1 India Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 10.2 Infectious Disease Point of Care Diagnostics Key Players in India
    • 10.3 India Infectious Disease Point of Care Diagnostics Market Size by Type
    • 10.4 India Infectious Disease Point of Care Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 11.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type
    • 11.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019))
      • 12.1.5 Abbott Recent Development
    • 12.2 Siemens
      • 12.2.1 Siemens Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.2.5 Siemens Recent Development
    • 12.3 GE Healthcare
      • 12.3.1 GE Healthcare Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.3.5 GE Healthcare Recent Development
    • 12.4 Accriva
      • 12.4.1 Accriva Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.4.5 Accriva Recent Development
    • 12.5 Terumo
      • 12.5.1 Terumo Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.5.5 Terumo Recent Development
    • 12.6 BioMerieux
      • 12.6.1 BioMerieux Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.6.5 BioMerieux Recent Development
    • 12.7 Diasorin
      • 12.7.1 Diasorin Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.7.5 Diasorin Recent Development
    • 12.8 Roche
      • 12.8.1 Roche Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.8.5 Roche Recent Development
    • 12.9 Danaher Corporation
      • 12.9.1 Danaher Corporation Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.9.5 Danaher Corporation Recent Development
    • 12.10 BD
      • 12.10.1 BD Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.10.5 BD Recent Development
    • 12.11 Bio-Rad Laboratories
    • 12.12 Cavidi
    • 12.13 Cepheid
    • 12.14 Diaxonhit
    • 12.15 Eiken Chemical
    • 12.16 EMD Millipore
    • 12.17 Epitope Diagnostic
    • 12.18 Euroimmun
    • 12.19 Gold Standard Diagnostics
    • 12.20 Hologic
    • 12.21 Immunetics
    • 12.22 InBios International

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott
      Siemens
      GE Healthcare
      Accriva
      Terumo
      BioMerieux
      Diasorin
      Roche
      Danaher Corporation
      BD
      Bio-Rad Laboratories
      Cavidi
      Cepheid
      Diaxonhit
      Eiken Chemical
      EMD Millipore
      Epitope Diagnostic
      Euroimmun
      Gold Standard Diagnostics
      Hologic
      Immunetics
      InBios International

      Market segment by Type, the product can be split into
      Over-the-counter (OTC) Testing Kits
      Prescription-based Testing Kits

      Market segment by Application, split into
      Bacterial Infections
      Fungal Infection
      Virus Infection
      Cardiovascular Infection
      Gastrointestinal Infection
      Sexually Transmitted Disease (STD) Infection
      Central Nervous System Infection
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Infectious Disease Point of Care Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now